ORPHAN Trademark

Trademark Overview

On Monday, June 17, 2002, a trademark application was filed for ORPHAN with the United States Patent and Trademark Office. The USPTO has given the ORPHAN trademark a serial number of 78136332. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 19, 2016. This trademark is owned by Swedish Orphan International AB. The ORPHAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of orphan diseases, namely, diseases related to hematology, genetic disorders, infectious diseases, metabolic disorders, oncology, respiratory diseases, poison control, diseases affecting immunocompromised patients, urology, Tyrosinemia Type I, and kidney stones associated with metabolic etiology; medicines for human use, namely, medicines for the treatment of orphan diseases, namely, diseases related to hematology, genetic disorders, infectious diseases, metabolic disorders, oncology, respiratory diseases, poison control, diseases affecting immunocompromised patients, urology, Tyrosinemia Type I, and kidney stones associated with metabolic etiology; and pharmaceutical preparations and medicine for human use for treatment of pain
orphan

General Information

Serial Number78136332
Word MarkORPHAN
Filing DateMonday, June 17, 2002
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 19, 2016
Registration Number3654760
Registration DateTuesday, July 14, 2009
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 28, 2009

Trademark Statements

Disclaimer with Predetermined Text"ORPHAN"
Description of MarkThe mark consists of a design of a globe with lines and the word "ORPHAN" in the middle of the globe.
Goods and ServicesPharmaceutical preparations for use in the treatment of orphan diseases, namely, diseases related to hematology, genetic disorders, infectious diseases, metabolic disorders, oncology, respiratory diseases, poison control, diseases affecting immunocompromised patients, urology, Tyrosinemia Type I, and kidney stones associated with metabolic etiology; medicines for human use, namely, medicines for the treatment of orphan diseases, namely, diseases related to hematology, genetic disorders, infectious diseases, metabolic disorders, oncology, respiratory diseases, poison control, diseases affecting immunocompromised patients, urology, Tyrosinemia Type I, and kidney stones associated with metabolic etiology; and pharmaceutical preparations and medicine for human use for treatment of pain

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 19, 2016
Primary Code005
First Use Anywhere DateMonday, April 15, 2002
First Use In Commerce DateMonday, April 15, 2002

Trademark Owner History

Party NameSwedish Orphan International AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressStockholm 111 60
SE
Party NameSwedish Orphan International AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressStockholm 111 60
SE
Party NameSwedish Orphan International AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressStockholm 111 60
SE

Trademark Events

Event DateEvent Description
Friday, February 19, 2016CANCELLED SEC. 8 (6-YR)
Tuesday, July 14, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, April 28, 2009PUBLISHED FOR OPPOSITION
Wednesday, April 8, 2009NOTICE OF PUBLICATION
Monday, March 23, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, March 19, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 19, 2009EXAMINER'S AMENDMENT ENTERED
Thursday, March 19, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 19, 2009EXAMINERS AMENDMENT E-MAILED
Thursday, March 19, 2009EXAMINERS AMENDMENT -WRITTEN
Thursday, March 19, 2009PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, March 16, 2009WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, March 3, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 3, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 3, 2009EXAMINER'S AMENDMENT ENTERED
Tuesday, March 3, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 3, 2009EXAMINERS AMENDMENT E-MAILED
Tuesday, March 3, 2009EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 11, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 11, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 11, 2009TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Saturday, September 27, 2008REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, March 27, 2008REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, September 27, 2007REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, February 20, 2007REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, February 20, 2007ASSIGNED TO LIE
Wednesday, August 9, 2006REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, January 12, 2006REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, June 16, 2005REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, June 1, 2005ASSIGNED TO EXAMINER
Tuesday, May 31, 2005ASSIGNED TO EXAMINER
Monday, March 21, 2005ASSIGNED TO EXAMINER
Tuesday, March 8, 2005ASSIGNED TO EXAMINER
Monday, March 7, 2005ASSIGNED TO EXAMINER
Tuesday, October 26, 2004REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, March 22, 2004CASE FILE IN TICRS
Monday, September 15, 2003TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 5, 2003LETTER OF SUSPENSION E-MAILED
Monday, April 14, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 14, 2003PAPER RECEIVED
Thursday, October 10, 2002NON-FINAL ACTION MAILED
Tuesday, October 1, 2002ASSIGNED TO EXAMINER

Related Keywords

orphan diseases disorders metabolic namely treatment urology type tyrosinemia patients kidney